Literature DB >> 33723336

Non-specific interactions of antibody-oligonucleotide conjugates with living cells.

Victor Lehot1, Isabelle Kuhn1, Marc Nothisen1, Stéphane Erb2, Sergii Kolodych3, Sarah Cianférani2, Guilhem Chaubet1, Alain Wagner4.   

Abstract

Antibody-Oligonucleotide Conjugates (AOCs) represent an emerging class of functionalized antibodies that have already been used in a wide variety of applications. While the impact of dye and drug conjugation on antibodies' ability to bind their target has been extensively studied, little is known about the effect caused by the conjugation of hydrophilic and charged payloads such as oligonucleotides on the functions of an antibody. Previous observations of non-specific interactions of nucleic acids with untargeted cells prompted us to further investigate their impact on AOC binding abilities and cell selectivity. We synthesized a series of single- and double-stranded AOCs, as well as a human serum albumin-oligonucleotide conjugate, and studied their interactions with both targeted and non-targeted living cells using a time-resolved analysis of ligand binding assay. Our results indicate that conjugation of single strand oligonucleotides to proteins induce consistent non-specific interactions with cell surfaces while double strand oligonucleotides have little or no effect, depending on the preparation method.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33723336      PMCID: PMC7961061          DOI: 10.1038/s41598-021-85352-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  33 in total

1.  Automated, high-resolution cellular retention and uptake studies in vitro.

Authors:  Henrik Björke; Karl Andersson
Journal:  Appl Radiat Isot       Date:  2006-04-18       Impact factor: 1.513

2.  Phosphorothioate oligodeoxynucleotides distribute similarly in class A scavenger receptor knockout and wild-type mice.

Authors:  M Butler; R M Crooke; M J Graham; K M Lemonidis; M Lougheed; S F Murray; D Witchell; U Steinbrecher; C F Bennett
Journal:  J Pharmacol Exp Ther       Date:  2000-02       Impact factor: 4.030

3.  RNA interference: a mammalian SID-1 homologue enhances siRNA uptake and gene silencing efficacy in human cells.

Authors:  Mark S Duxbury; Stanley W Ashley; Edward E Whang
Journal:  Biochem Biophys Res Commun       Date:  2005-06-03       Impact factor: 3.575

4.  Mechanisms and optimization of in vivo delivery of lipophilic siRNAs.

Authors:  Christian Wolfrum; Shuanping Shi; K Narayanannair Jayaprakash; Muthusamy Jayaraman; Gang Wang; Rajendra K Pandey; Kallanthottathil G Rajeev; Tomoko Nakayama; Klaus Charrise; Esther M Ndungo; Tracy Zimmermann; Victor Koteliansky; Muthiah Manoharan; Markus Stoffel
Journal:  Nat Biotechnol       Date:  2007-09-16       Impact factor: 54.908

5.  Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancer.

Authors:  W H Kuijpers; E S Bos; F M Kaspersen; G H Veeneman; C A van Boeckel
Journal:  Bioconjug Chem       Date:  1993 Jan-Feb       Impact factor: 4.774

6.  Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB-siRNA conjugates.

Authors:  Trinna L Cuellar; Dwight Barnes; Christopher Nelson; Joshua Tanguay; Shang-Fan Yu; Xiaohui Wen; Suzie J Scales; Julie Gesch; David Davis; Anja van Brabant Smith; Devin Leake; Richard Vandlen; Christian W Siebel
Journal:  Nucleic Acids Res       Date:  2014-12-30       Impact factor: 16.971

7.  SIDT2 mediates gymnosis, the uptake of naked single-stranded oligonucleotides into living cells.

Authors:  Masayuki Takahashi; Viorica Raluca Contu; Chihana Kabuta; Katsunori Hase; Yuuki Fujiwara; Keiji Wada; Tomohiro Kabuta
Journal:  RNA Biol       Date:  2017-04-17       Impact factor: 4.652

Review 8.  Therapeutic Applications of Pretargeting.

Authors:  Marjolein Verhoeven; Yann Seimbille; Simone U Dalm
Journal:  Pharmaceutics       Date:  2019-09-01       Impact factor: 6.321

9.  Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver.

Authors:  Colton M Miller; Aaron J Donner; Emma E Blank; Andrew W Egger; Brianna M Kellar; Michael E Østergaard; Punit P Seth; Edward N Harris
Journal:  Nucleic Acids Res       Date:  2016-02-22       Impact factor: 16.971

10.  On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency.

Authors:  Igor Dovgan; Anthony Ehkirch; Victor Lehot; Isabelle Kuhn; Oleksandr Koniev; Sergii Kolodych; Alexandre Hentz; Manon Ripoll; Sylvain Ursuegui; Marc Nothisen; Sarah Cianférani; Alain Wagner
Journal:  Sci Rep       Date:  2020-05-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.